ArticleInflammopharmacology2019

Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis.

Philipp Guenthoer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.